MLN64, is invariably coamplified and coexpressed with erbB-2 in breast cancers. The human MLN64 and ERBB2 genes are positioned at less than 50 kb from each other, on chromosome 17q12. To understand the molecular basis of MLN64 overexpression in cancer, the genomic region containing the MLN64 and ERBB2 genes was isolated and mapped. The two genes, DARPP32 and Telethonin, flanking MLN64 respectively on its centromeric and telomeric sides, although coamplified, are not overexpressed in breast cancer cells, indicating that gene amplification is not sufficient to allow overexpression. The MLN64 minimal promoter was isolated and found to be a housekeeping gene promoter containing four potential Sp1 binding elements. Using Sp1-deficient Drosophila SL2 cells, MLN64 promoter activity was induced in a dosedependent manner by exogenous Sp1 addition. Furthermore, mutation of each individual Sp1 element resulted in a significant decrease in reporter gene activity, indicating that all the Sp1 binding elements are functional and act together to promote gene expression. Since the ERBB2 promoter is also positively regulated by Sp1, this study indicates that MLN64 and ERBB2 genes share common transcriptional controls together with a physical link on chromosome 17q. We speculate that, in addition to the oncogenic potential of erbB-2 overexpression, the unbalanced action of MLN64 contributes to the poor clinical outcome of breast tumors bearing this amplified region.
Introduction
Human metastatic lymph node (MLN) 64 cDNA was identified from a breast cancer-derived metastatic lymph node cDNA library by differential hybridization using malignant (MLN) versus nonmalignant (breast fibroadenoma and normal lymph node) tissues (Tomasetto et al. , 1995a) . MLN64 cDNA encodes a protein of 445 residues that can be divided into two domains. The amino-terminal half of the protein contains four potential transmembrane regions and targets the protein to the membrane of late endosomes (Alpy et al., 2001) . Recently, we have isolated a novel late-endosomal protein, MENTHO (MLN64 N-terminal domain homologue), structurally related to the amino-terminal half of MLN64. MENTHO and MLN64 share 70% identity and 83% similarity in an original protein domain that we designated as the MENTAL (MLN64 N-TerminAL) domain (Alpy et al., 2002) . The carboxy-terminal half of the protein is structurally related to the steroidogenic acute regulatory (StAR) protein . StAR is a mitochondrial protein that regulates the acute production of steroids in the adrenal and gonads in response to corticotropin and luteinizing hormone, respectively (Stocco, 2001) . The functional relation between MLN64 and StAR was previously addressed. It was shown that, like StAR, MLN64 can enhance steroidogenesis in vitro (Watari et al., 1997) . Moreover, the region conserved between StAR and MLN64, the StAR-related transfer (START) domain was shown to be a cholesterol-binding domain for both proteins (Tsujishita and Hurley, 2000) . While StAR acts as a sterol-carrier directly on the mitochondria (King et al., 1995; Arakane et al., 1998) , MLN64 is involved in the cholesterol transport from endosome to cytoplasmic acceptor(s) (Alpy et al., 2001) .
Chromosomal mapping showed that the MLN64 gene is located in the q12-q21 region of long arm of the chromosome 17 (Tomasetto et al., 1995a) . This region is altered in 20-30% of breast cancers, the most common modification being the amplification of proto-oncogene ERBB2 (Slamon et al., 1987) . Amplification of ERBB2 is a marker of poor prognosis and tumor aggressiveness in breast cancers and its overexpression in tumors has been correlated to therapy failure (Pegram et al., 1998; Ross and Fletcher, 1999) . Although amplification involves a significant chromosomal region, bearing several genes, it is commonly believed that a single gene is the driving force for this mechanism. Nevertheless, recent evidences suggest that ERBB2 is not the unique target gene that is activated by the 17q12-q21 amplification in breast cancer. For instance, large-scale expression profiling of human breast cancer has identified a subset of genes coexpressed with ERBB2 (Pollack et al., 1999; Perou et al., 2000) . As mentioned by previous studies, many of these genes are clustered on the q12 region of chromosome 17 where the ERBB2 gene lies. The gene encoding the adapter protein growth receptor bound 7 (grb7) belongs to this cluster (Stein et al., 1994) . grb7, a member of the grb2 protein family, plays a fundamental role in tyrosine kinase signaling (Daly, 1998) . Most importantly, Stein et al. (1994) have demonstrated a direct interaction between erbB-2 and grb7 in breast cancer biopsies. In addition, coamplification and coexpression of grb7 with EGFR or erbB-2 was significantly related to cancer progression in esophageal cancers (Tanaka et al., 1997 (Tanaka et al., , 2000 . These results show that a functional cooperation between erbB-2 and grb7 is deleterious for the tumor outcome. MLN64, also belongs to this gene cluster and is invariably overexpressed with erbB-2 in breast and ovarian cancers (Tomasetto et al., 1995a; Bieche et al., 1996; Kauraniemi et al., 2001) . Therefore, similar to ERBB2 and GRB7, MLN64 may be an additional target gene within 17q12 amplicon and could be involved in breast cancer development and/or progression.
To understand the molecular basis of MLN64 overexpression in cancer, we have studied its gene structure and characterized its promoter.
Results

Human MLN64 gene organization
Using the complete MLN64 cDNA (Accession no. X80198) as a probe, we isolated clones from a human normal leukocyte genomic library; all of the positive clones lacked the first exon. To obtain the 5 0 missing region of the gene, the library was screened again, using a small 5 0 cDNA fragment corresponding to the first exon of MLN64. Clones showing a positive signal with both the 5 0 and the complete cDNA probes were purified and analysed. Restriction map analysis of eight independent clones allowed the deduction of the complete MLN64 gene structure. We confirmed our analysis using sequence release from the human genome sequencing project (Accession no. AC040933). Three BamHI genomic fragments of 6.5, 4.0 and 10.0 kb including respectively exon 1, exon 2 and exons 3-15 were subcloned and partially sequenced to map splicing sites. Intron sizes were estimated either by sequencing or by PCR amplification. The MLN64 gene is split into 15 exons located along 26 kb of genomic DNA (Figure 1) . Most of the 5 0 untranslated region is contained within the first exon and the start codon is located at position 52 of exon 2. The stop codon and the polyadenylation signal are located at positions 103 and 646 of exon 15, respectively. The MLN64 exons range in size between 54 bp (exon 5) and 270 bp (exon 2) with the exception of exon 15 (666 bp), the largest exon. The 14 introns of the MLN64 gene range in size between 91 bp (intron 12) and 16 247 bp (intron 1). All introns show the consensus 5 0 donor and 3 0 acceptor splicing sequences GT/AT (Breathnach and Chambon, 1981) .
MENTHO, StAR and MLN64 share a similar gene organization in their conserved domains
The MLN64 protein is composed of two parts: the amino-terminal half (residues 1-230) which contains the MENTAL domain that is encoded by exons 2-7 ( Figure 1a ) and the carboxy-terminal START domain (residues 231-445) that is encoded by exons 9-15.
The MENTAL domains of MENTHO and MLN64 are conserved, sharing 70% identity and 83% similarity (Alpy et al., 2002) . The gene structure of MENTHO was obtained using the human genome sequence data base (accession no. NT_007819) and compared with the MLN64 gene structure. The gene organization within the conserved MENTAL domains of MENTHO and MLN64 is identical and encoded by exons 2-7 ( Figure 1a ). In the MLN64 gene, exon 8 encodes a nonconserved linker region between the MENTAL and START domains.
The START domains of StAR and MLN64 are related, exhibiting 35% identity and 54% similarity. As the human StAR gene structure is known (Sugawara et al., 1995) , we compared the organization of the genomic region encoding the START domain of both MLN64 and StAR. Interestingly, the exon boundaries in the START encoding region of StAR gene and MLN64 gene are conserved (Figure 1a) . However, while the START domain of StAR is encoded by five exons (3-7), the START domain of MLN64 is encoded by seven exons (9-15). It is interesting to note that two additive introns are present within the MLN64-START domain genomic sequence.
The MLN64 gene lies in a gene-dense region
We previously mapped the MLN64 gene to the long arm of chromosome 17, within the q12-q21 region (Tomasetto et al., 1995a) . In addition, we and others have shown that MLN64 and ERBB2 are invariably coamplified in breast cancer (Bieche et al., 1996; Kauraniemi et al., 2001; Hyman et al., 2002; Pollack et al., 2002) . From the human genome sequence, MLN64 is located in a centromeric position 30-40 kb from ERBB2. Several genes are present in the genomic region that contains MLN64 and ERBB2, such those encoding grb7 (Stein et al., 1994) , the phenylethanolamine N-methyltransferase (PNMT) and several putative proteins (Figure 1b) . The MLN64 gene was found to be closely flanked by two genes. At the 5 0 end, 513 bp upstream of MLN64 transcription start site, lies the 3 0 end of the last exon of the dopamine and cAMP regulated neuronal phosphoprotein-32 (DARPP-32) gene (Figure 1b) . DARPP-32 plays a critical role in dopaminergic neuro transmission and is expressed in the brain and ovary (Fienberg et al., 1998; Mayerhofer et al., 1999) . In the 3 0 position, 1880 bp downstream of exon 15
Characterization of the MLN64 gene and promoter F Alpy et al of MLN64 lies the transcription start site of the Telethonin gene (Figure 1b ). Telethonin is a sarcomeric protein expressed in the heart and skeletal muscles (Valle et al., 1997) .
Coordinated overexpression of MLN64 and erbB-2
Within the genes present in the ERBB2 amplicon, the MLN64 gene is always coamplified and also co-overexpressed with erbB-2 in breast and ovarian tumors. To verify if this is a general feature of the genes in this region, we have studied amplification and overexpression of the two MLN64 neighboring genes, DARPP-32 and Telethonin in different cancer cell lines. Southern blot analysis showed that the DARPP-32 and Telethonin genes were amplified together with ERBB2 and MLN64 in the SK-OV-3, MDA-MB-453, SK-BR-3 and BT-474 cell lines (Figure 2a lanes 3, 4, 6 and 7). However, Telethonin mRNA was not detected in any of the cell lines studied here (Figure 2b ). Similarly, DARPP32 was solely detected in an ovarian-derived cell line ( Figure 2b , lane 3), a tissue where the gene is normally expressed (Fienberg et al., 1998; Mayerhofer et al., 1999) . These experiments show that amplification of a cluster of genes is not sufficient to drive the overexpression of all of the genes present in the cluster, and indicate that in addition to their common chromosomal localization MLN64 and ERBB2 may share transcriptional controls.
Promoter of the MLN64 gene
To understand the regulation of MLN64 expression, we have isolated and characterized its regulatory sequences. Sequence analysis of the 5 0 flanking region of exon 1 Schematic representation of the genes present in the vicinity of the MLN64 gene. Physical position of known and hypothetical genes located in the q12-q21 region of human chromosome 17. Gene orientation is indicated by an arrow. This map was built using the human chromosome 17 sequence segment (Accession no. NT_010799) and by our sequencing of MLN64 genomic clones. DARPP32, dopamine and cAMP regulated phosphoprotein (Accession no. AF233349); MLN64, metastatic lymph node 64 (Accession no. X80198); Telethonin or titin cap (TCAP) (Accession no. NM 003673); PNMT, phenylethanolamine N-methyltransferase (Accession no. NM 002686); MGC9753 (Accession no. XM 053326); ERBB2, avian erythroblastic leukemia viral oncogene homolog 2 (Accession no. NM 004448); MGC14832 (Accession no. XM 049821); GRB7, growth factor receptor-bound protein 7 (Accession no. XM 012695)
Characterization of the MLN64 gene and promoter F Alpy et al revealed a high GC content and lack of a canonical TATA-box ( Figure 3 ). In addition, a CpG island spanning the 5 0 end and the first noncoding exon of MLN64 was found ( Figure 1a ). The CpG-rich region is about 1200 bp long. Its GC-content is 60.7% with an overall observed CpG over expected CpG ratio of 0.75. As commonly found for TATA-less promoters (Smale, 1997) , primer extension or RACE-PCR studies did not lead to the identification of a major transcription start site and transcription initiation spans the entire first exon. The most distal transcription initiation site was designated by the alignment of 20 expressed sequence tag (EST) sequences present in the database and covers the first exon of MLN64 (Figure 3 ).
Sequential deletion fragments of the 5 0 upstream region of the MLN64 gene were subcloned upstream of the luciferase reporter gene (Figure 4a ). Luciferase reporter activity was measured after transient transfection of an epithelial kidney-derived cell line (HEK293) using different overlapping constructs. A 0.2 kb DNA fragment upstream from the transcription start site was sufficient to drive high expression of the reporter gene (Figure 4a ), while adding up to 1.5 kb of upstream DNA sequences decreased promoter activity. DNA fragments shorter than the 0.2 kb had a reduced promoter activity. Thus, the MLN64 minimal promoter is contained within the 200 bp DNA fragment upstream of the transcription start site.
The MLN64 messenger RNA is expressed at low levels in all tissues . To determine whether the MLN64 5 0 flanking region can direct expression in an ubiquitous manner, the proximal 0.5 and 0.2 kb promoter constructs were transiently transfected in a panel of different cell lines. In all of the lines tested, established from ovary (SK-OV-3), cervix (HeLa), stomach (AGS), breast (MCF7), fetal kidney (HEK293) and mouse preadipocyte (3T3L1), the 0.5 kb MLN64 5 0 -flanking region was able to promote high expression of the reporter gene ( Figure 4b and not shown). In addition, the short 0.2 kb promoter fragment was significantly more active than the 0.5 kb fragment, which includes all of the sequences between the last exon of DARPP32 and the first exon of MLN64. This suggests that sequences acting negatively upon transcription are present in the distal part of the MLN64 5 0 -flanking sequences.
Sp1 regulation of MLN64
Within the 0.5 kb upstream sequence of MLN64, five putative Sp1 binding elements and one potential consensus site for the transcription factors NF-kB and C/EBPb were found (Figure 3) . However, the MLN64 0.2 kb minimal promoter contains only four potential Sp1 binding sites, suggesting that NF-kB and C/EBPb do not regulate MLN64 expression significantly in the models used in this study (Figure 4a ). In fact, stimuli such as TNFa, cyclic AMP and phorbol esters (TPA) did not increase MLN64 mRNA levels in HEK293 and SK-OV-3 cells (Figure5a and not shown). In addition, cotransfection of a C/EBPb expression vector with the MLN64 promoter constructs in HEK293 cells did not increase MLN64 promoter activity (not shown). Altogether these results confirm that in the cellular models used, NF-kB and C/EBPb do not regulate MLN64 expression. We next examined whether the Sp1 transcription factor could be a major transcriptional activator of the MLN64 gene. To directly assess the contribution of Sp1 to MLN64 gene transcription, we took advantage of the Sp1-defective Drosophila SL2 cellular model (Courey and Tjian, 1988) . When pGL3-0.2-MLN64 was transfected in SL2 cells no reporter activity was detected (Figure 5b ). In contrast, cotransfection with increasing amounts of a Sp1 expression plasmid resulted in a dosedependent rise of luciferase reporter gene activity Characterization of the MLN64 gene and promoter F Alpy et al (Figure 5b ), thus demonstrating that MLN64 transcription is mediated by Sp1 or by a member of this transcription factor family.
To discriminate between the four potential Sp1 binding elements, mutations of each individual element designated as Sp1a-d (Figure 5c ) were generated in the pGL3-0.2-MLN64 reporter gene construct. In HEK293 cells, every mutation resulted in a decrease in luciferase activity (Figure 5c ). To verify whether this result could be attributed to the Sp1 transcription factor, the same experiment was performed in Drosophila Sp1-defective cells. Constructs bearing wild-type or mutated MLN64 promoters at single or all Sp1 binding elements were transfected in SL2 cells. Luciferase activity was measured in the absence or presence of exogenous Sp1 protein. As shown in Figure 5c , wild-type and mutated MLN64 promoter constructs showed no reporter activity in the absence of exogenous Sp1; in the presence of exogenous Sp1, a mutation at any single Sp1 binding element (a, b, c or d) resulted in decreased reporter gene activity. A mutation in the Sp1 motif b or c (position À53 À45 and À78 À70, Figure 3 ) resulted in a significant decrease in luciferase activity matching the level obtained when all the four Sp1 binding elements are mutated (Figure 5c) .
In HEK293 cells, mutation of each single Sp1 site resulted in a strong decrease of reporter activity. In the presence of exogenous Sp1 in SL2 cells, all of the Sp1 binding motifs identified were functional, however the motifs, Sp1b and Sp1c contributed most significantly to MLN64 promoter transactivation. Thus, under the conditions used in this study, the Sp1 transcription factor plays a major role in the transactivation of the MLN64 promoter.
Discussion
Gene amplification is a common feature of human breast cancers (Bieche and Lidereau, 1995) . In breast tumors, as in breast cancer-derived cell lines, the amplification of the q11-21 region of chromosome 17 is frequent (Kallioniemi et al., 1992; Guan et al., 1994; Muleris et al., 1994) . Tumors bearing an amplification of 17q11-21 are associated to an adverse prognosis and to resistance to both chemotherapy and endocrine Ross and Fletcher, 1999) . The erbB-2 oncogene, a member of the epidermal growth factor receptor (EGFR) gene family (Hynes et al., 2001) , lies in this region and is believed to be responsible for the poor outcome of these tumors (Slamon et al., 1987) . Interestingly, it has been found that within this segment of the genome, several genes including growth factor bound protein (grb) 7 and MLN64 are invariably coamplified and coexpressed in tumors and cultured cell lines (Stein et al., 1994; Tomasetto et al., 1995a; Bieche et al., 1996; Kauraniemi et al., 2001; Hyman et al., 2002; Pollack et al., 2002) . A functional cooperation between erbB-2 and grb7 has been reported and suggests that a synergistic action of both proteins in cancer cells may contribute to the poor outcome of these tumors (Stein et al., 1994) . In this context, the action of other proteins such as MLN64 could also account for the deleterious progression of these tumors. We demonstrated that the coamplification of MLN64 and ERBB2 is because of the close association of their genes (Tomasetto et al., 1995a) , this association is also conserved in the mouse genome (F Alpy and C Tomasetto, unpublished). Indeed MLN64 and ERBB2 are located at 30-40 kb of each other on chromosome Figure 4 Functional analysis of the human MLN64 promoter. (a) On the top left, schematic representation of MLN64 upstream sequence and position of the putative binding sites for the Sp1, C/EBPb and NF-kB transcription factors. Below, description of the luciferase reporter plasmid constructs that were transfected in HEK293 cells. Their corrected relative luciferase activities are shown on the right. pGL3 basic vector was chosen as a reference and was arbitrarily assigned a value of 1. The activities of the deletion constructs were assigned as fold-changes relative to pGL3. (b) Two promoter constructs described in (a), pGL3-0.5-MLN64 and pGL3-0.2-MLN64 were transfected in SK-OV-3, HeLa, AGS, MCF7 and HEK293 cells, and luciferase activities were measured and corrected as described above. The normalized relative luciferase activities (mean) of a representative experiment performed in duplicate are shown in a form of a graph bar, error bars represent standard deviations. Experiments were performed three (a) and two (b) times Characterization of the MLN64 gene and promoter F Alpy et al 17q11-12. This region is gene-rich (Caron et al., 2001) and by sequencing analysis of MLN64-positive genomic clones, we showed that MLN64 is closely flanked by two genes. On the centromeric side, the DARPP32 gene is 0.5 kb upstream of the MLN64 transcriptional start site; on the telomeric side, the Telethonin gene starts 2 kb downstream of the 3 0 end of the MLN64 gene. As expected from their location, DARPP32 and Telethonin genes are also coamplified with MLN64 and ERBB2.
However, unlike MLN64 we observed that these two genes, although amplified, are not expressed in breast cancer cells. Since epigenetic abnormalities such as DNA undermethylation are often found in cancers (Ehrlich, 2002) , and given the presence of a CpG island at the 5 0 end of MLN64, the 5 0 regions of DARPP32 and Telethonin genes were studied for the presence of CpG islands. Indeed transcriptional silencing can be mediated by hypermethylation of the CpG island-containing The MLN64 promoter contains the typical features of a housekeeping gene promoter, no TATA box and several GC-rich elements. As a common feature of a TATA-less promoter (Smale, 1997) , MLN64-transcription initiation starts at multiple sites spanning the entire first exon, and no major sites could be identified. MLN64 regulatory sequences are contained within a 0.5 kb upstream region. By sequential deletion analysis, a 0.2 kb upstream fragment was found to be sufficient to promote maximal reporter gene activity in transfected cells. In agreement with the ubiquitous expression of MLN64 mRNA, MLN64 promoter activity was found to be high in all the cell lines tested, further indicating that ubiquitous regulators such as Sp transcription factor family members might control its expression. Although a C/EBPb, NF-kB and five Sp1 potential binding sites were found in the 0.5 kb MLN64 upstream sequence, only four potential Sp1 binding sites were present in the 0.2 kb upstream fragment that exhibits full promoter activity. Accordingly, TNFa or TPA treatment failed to induce reporter gene activity and increase MLN64 mRNA levels in HEK293 and SK-OV-3 cells. To demonstrate directly Sp1 activity, Drosophila SL2 cells lacking Sp1 (Courey and Tjian, 1988) were used to study the effect of Sp1 in vivo. Cotransfection of a Sp1 expression plasmid increased promoter-directed reporter gene expression in a dose-dependent manner. Mutation of the Sp1 binding motifs resulted in an inhibition of MLN64-promoter transactivation, thus confirming the function of Sp1 or a member of this family in regulating MLN64 expression. Interestingly Sp1 binding sites are present in the promoter of the human, mouse and rat ERBB2 genes (Bates and Hurst, 1997) and positive regulation of the human ERBB2 gene by Sp1 has been documented in Drosophila SL2 cells (Chen and Gill, 1994) . Therefore, the MLN64 and ERBB2 promoters share Sp1 binding sites and are likely to be coregulated by transcription factors binding to these motifs.
Sp1 binding sites are present in a large variety of promoters. They represent promoter elements that support basal constitutive transcription of housekeeping genes. However, the identification of several transcription factors with high homology to Sp1, the Sp and Kru¨ppel-like factor family (Sp/KLF), indicates that transcription from Sp1 sites is very complex. To date, the Sp/KLF family contains at least 20 identified members including the four very similar Sp factors (Sp1-4) and Kru¨ppel-like factors. Although all members bind to similar DNA target sites, they differ by their relative affinities for specific sequences, their expression patterns and their transcriptional activities. Sp/KLF factors are involved in many growth-related signal transduction pathways and altered expression of some members of this family has been detected in tumors (Black et al., 2001) . Large-scale analysis of gene expression patterns in breast cancers did not identify a Sp/KLF family member among the cluster of genes coexpressed with erbB-2 (Perou et al., 2000) . Since these factors can be modulated at the post-translational level, functional alteration of one or several of these factors may occur in the absence of significant changes in expression pattern. Interestingly, using in situ hybridization and immuno-histochemistry, a member of this family, the gut-enriched kru¨ppel-like factor (GKLF), was recently found to be overexpressed during breast cancer progression (Foster et al., 2000) . Our results indicate that the common expression of MLN64 and ERBB2 genes in cancer may be mediated by Sp/KLF family member(s), and that the contribution of GKLF should be investigated.
Molecular profiling of breast cancer samples using microarray-based technology has shown that several genes overexpressed with erbB-2 are located in the same region of chromosome 17. However, this finding is not a common feature of all the genes present in this region. Indeed, as shown here and previously reported by others, many of the amplified genes are not overexpressed in tumors (Pollack et al., 1999; Perou et al., 2000) . MLN64 and ERBB2 genes share a physical link on chromosome 17q and similar regulatory elements. Recently, growing evidence suggests that genes are not randomly distributed along chromosomes. In fact, the clustering of nonhomologous genes coexpressed under similar conditions and involved in common biological processes has been described in worms (Blumenthal et al., 2002) , flies (Boutanaev et al., 2002; Cohen et al., 2000) and mammals (Soury et al., 2001; Lercher et al., 2002) . These findings suggest that to achieve a complex biological pathway, the coordinate expression of several clustered genes present in open chromatin regions may be advantageous. Therefore, we speculate that erbB-2, grb7, MLN64 and other as yet uncharacterized proteins present in the 17q12 (ERBB2) cluster are involved in a common biological pathway, and that the unbalanced action of these proteins in breast tumors may contribute to their poor clinical outcome.
Materials and methods
MLN64 genomic DNA cloning
A human normal blood genomic library was constructed in a lambda EMBL 301 vector and screened as previously described (Regnier et al. , 1995) . Briefly, 1 million plaque forming units were screened in duplicate using two human MLN64 cDNA probes: the first probe corresponds to a short 5 0 fragment (nucleotides 1-80, Accession no. X80198) amplified by polymerase chain reaction and the second probe corresponds to the complete cDNA (Accession no. X80198). This screening allowed the isolation of eight independent clones positive for either one of the probes. Restriction mapping of the lambda clones allowed the identification of MLN64 gene organization. Several overlapping BamHI fragments of these lambda clones were subcloned into pBluescript II vector (Stratagene, La Jolla, CA, USA) and positioned with respect to the MLN64 cDNA sequence.
Cell culture
The human cell lines (AGS, BT-20, BT-474, HBL-100, HEK293, HeLa, MCF7, MDA-MB-231, MDA-MB-453, RD, SK-OV-3, SK-BR-3), the mouse 3T3L1 and Drosophila melanogaster SL2 cells are described and available in the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were routinely maintained in our laboratory and cultured as recommended. SK-OV-3 and HEK293 cells were treated with 100 ng/ml of hTNFalpha (R&D, Minneapolis, MN, USA) or with 50 ng/ml of TPA (Sigma, St Louis, MO, USA) for 24 h, washed once with cold PBS and subjected to RNA extraction.
RNA extraction and Northern blot analysis
RNAs from cell lines were extracted using the single-step procedure of Chomczynski and Sacchi (1987) . RNAs were fractionated by electrophoresis on 1% agarose, 2.2 m formaldehyde gels (Lehrach et al., 1977) , transferred to nylon membrane (Hybond N, Amersham Corp., Arlington Heights, IL, USA) and immobilized by baking for 2 h at 801C. Northern blots were hybridized at 421C in 50% formamide, 5 Â standard saline citrate (SSC), 0.4% Ficoll, 0.4% polyvinylpyrrolidone (PVP), 20 mm sodium phosphate pH 6.5, 0.5% sodium dodecyl sulfate (SDS), 10% dextran sulfate and 100 mg/ml denatured salmon sperm DNA, for 36-48 h with 32 Plabeled probes (Feinberg and Vogelstein, 1983) diluted to 0.5-1 Â 10 6 cpm/ml. Stringent washes were performed at 601C in 0.1 Â SSC and 0.1% SDS. Blots were autoradiographied at À801C for 24 h.
Genomic DNA extraction and Southern blot analysis
Cells were grown in 75-mm 2 flasks to confluency and washed with PBS 1 Â . After addition of 2 ml extraction buffer (10 mm Tris-HCl, pH 8.0, 0.1 m Na 2 EDTA, pH 8.0, 20 mg/ml RNase A, 0.5% SDS, 100 mg/ml proteinase K), the flasks were incubated at 501C for 12 h. Genomic DNA was recovered by precipitation with one volume of isopropanol. After washing in 70% ethanol, DNA was air-dried and dissolved in TE (10 mm Tris-HCl, pH 7.5, 1 mm Na 2 EDTA, pH 8.0) at 41C. For gene-amplification studies, 10 mg of genomic DNA was digested until completion by EcoRI, fractionated on 0.8% agarose gel and blotted onto Hybond-N þ membrane (Amersham). Hybridization and washing were performed as described for Northern blot analysis.
Sequence analysis
Potential binding motifs for transcription factors were studied using the Transcription Element Search Software (TESS) (http://www.cbil.upenn.edu/tess) and MatInspector (Quandt et al., 1995) . The presence of CpG islands was studied using the chromosome 17 sequence (Accession no. NT_010799) and the CpG Island Search software (http://www.uscnorris.com/ cpgislands, Takai and Jones, 2002) .
Probes and plasmids
The MLN64 probe corresponded to the 2.0-kb complete cDNA (Accession no. X80198). The probe for Telethonin was an internal 400 bp fragment obtained by PCR using genomic BT-474 DNA as template and the following oligonucleotides as primers (5 0 -CTC CCT GCA TGA GGA GGA CAC C -3 0 and 5 0 -ACA GTC CCT CTC AGC CTC TCT G -3 0 ). The probe for DARPP32 was an internal fragment of 200 bp obtained by PCR using the 5 0 6.5 kb BamHI genomic MLN64 clone as template and the following oligonucleotides as primers (5 0 -CTG TGC AGC GCA TTG CTG AGT-3 0 and 5 0 -CAG ACT GCC TGA TGA CCT TCA-3 0 ). The 36B4 probe, used as a positive loading control, and the erbB-2 probe were described previously (Tomasetto et al., 1995b) . Overlapping upstream MLN64 promoter fragments were generated by PCR amplification using a genomic subclone in pBluescript of a BamHI fragment of 6.5 kb covering the first exon of MLN64 as template and the following sets of synthetic oligonucleotides as primers. The 1.5 kb, 0.5, 0.3, 0.2, 0.15, 0.1 and 0.06 upstream MLN64 genomic fragments were generated using (5 0 -TATCGATAGG TACCGAGCTC GG-GCCCTGGG AGCGCCCA-3 0 , 5 0 -TATCGATAGG TACC-GAGCTC CTGAGACTCC TCTTTCAG-3 0 , 5 0 -TATCGA-TAGG TACCGAGCTC CTTCTCGAAT AACTGGAT-3 0 , 5 0 -TATCGATAGG TACCGAGCTC CAGGCCTGTG TG-GCCTAATA-3 0 , 5 0 -TATCGATAGG TACCGAGCTC CCC-TACCCTT AGGTAGG-3 0 , 5 0 -GAGAGAGCTC CTGCGC-AGGG CCGGG-3 0 , 5 0 -GAGAGAGCTC GCAAGTCCCG CTTCG-3 0 ) as forward primers, respectively, and (5 0 -GCTAG-CACGC GTAAGAGCTC GATCTTCCGG CAGCGCCA-3 0 ) as the common reverse primer. The amplified fragments were then subcloned upstream of the firefly luciferase reporter gene into SacI digested pGL3basic vector (Promega Corp., Madison, WI, USA), thus generating pGL3-1.5-MLN64, pGL3-0.5-MLN64, pGL3-0.3-MLN64, pGL3-0.2-MLN64, pGL3-0.15-MLN64, pGL3-0.1-MLN64 and pGL3-0.06-MLN64 overlapping promoter reporter plasmids. Mutated Sp1 binding sites present in the MLN64 minimal promoter construct pGL3-0.2-MLN64 were generated by site-directed mutagenesis (QuickChange Site-Directed Mutagenesis kit, Stratagene) using the following synthetic oligonucleotides (5 0 -GCTTCGCTCA TATCGGACTCA GCGG-3 0 , 5 0 -CGGGG-CGAAG GATATCGGCC GCAGGC-3 0 , 5 0 -CTGCGCAG-GG ATATCGCTGG AGGCGGG -3 0 , 5 0 -GGTCTTCTTG A-ATTCCCCCT ACCCTTAGG-3 0 ) generating the constructs pGL3-0.2-MLN64DSp1a, pGL3-0.2-MLN64DSp1b, pGL3-0.2-MLN64DSp1c, pGL3-0.2-MLN64DSp1d, respectively. A construct containing mutations of the four Sp1 binding sites pGL3-0.2-MLN64DSp1abcd was generated by four successive site-directed mutagenesis using the primers described above. Plasmids allowing expression of the Sp1 transcription factor, pPacSp1 and the b-galactosidase expression vector pPac-CH110 were a kind gift of R Tjian. The IkB alpha and collagenase 1 specific probes were a kind gift of CH Re´gnier and P Basset, respectively.
Promoter activity analysis
For reporter gene assays, AGS, HeLa, SK-OV-3, MCF7, HEK293 cells and SL2 (1-5 Â 10 5 cells/well) were seeded into six-well (35 mm) plates. The next day, cells were transiently transfected using the calcium phosphate procedure or using Fugene6 transfection reagent (Roche Indianapolis, IN, USA) or using JetPEI transfection reagent (Poly-plus transfection Illkirch, France), with 2 mg of luciferase reporter plasmid. For normalization, 1 mg of pSV-beta-galactosidase plasmid (Promega) and 1 mg of pPac-CH110 were used as an normalization controls for mammalian and insect cells, respectively. For direct Sp1 transactivation assay, various amounts of pPac-Sp1 expression vector were added to the transfection mix. For NFkB and C/EBPb induction, 36 h later, cells were stimulated with TNFa (100 ng/ml) or TPA (50 ng/ml) for 24 h. For reporter gene activity measurement, cells were washed twice in PBS and after centrifugation the cell pellet was lysed with 150 ml of passive lysis buffer. Cellular debris were removed by centrifugation. A volume of 50 ml of cell supernatant was assayed for luciferase activity in a Luminometer (EG&G Berthold, Germany) and 50 ml for beta-galactosidase activity. All transfections were performed in duplicate or triplicate.
